The beauty market in 2024 continues to evolve rapidly, adapting to changing trends each year. Consumer demands and preferences are becoming increasingly diverse, not only in Korea but globally. With both local and international consumers showing strong enthusiasm for cosmetics, many experts predict that the K-beauty market will reach a value of 18 trillion won. Amid this growth, “cosmeceutical” is continuing sought for as a key beauty trend.

Cosmeceutical, a blend of “medical” and “cosmetic,” represent a beauty trend that incorporates medical principles into skincare, going beyond simple basic skincare routines. Focusing on healthy beauty rather than just aesthetic appeal, these products deliver high efficacy with professional treatment features, such as anti-aging and whitening. As cosmetic procedures become more common and continues to increase, products catering for post-procedure care are growing rapidly. A leading K-beauty cosmeceutical brand in this field is OxygenCeuticals by COIZ Co., Ltd.

COIZ has established a rigorous quality system for post-procedure skincare and, through continuous technological innovation, has built steady trust in the global market over the past 20 years. COIZ has established its footprints domestically and international as a specialized medical aesthetics company in Korea, achieving more than 60% of its total revenue through exports.

In particular, COIZ’s brand, Oxygenceuticals, has developed and manufactured specialized oxygen-based beauty devices exclusively for post-care. Their products integrate the biochemical benefits of pure oxygen, that are especially effective for post-procedure skin care needs. This focus has strengthened their brand recognition within the cosmeceutical market, which merges the benefits of pharmaceuticals and cosmetics.

Based on the concept of “breathing life into your sensitive skin,” OxygenCeuticals is recognized highly as being a low-irritant product line with proven safety.

Currently, COIZ actively exports to 40 countries and operates local branches in the United States and China. In Korea, over 800 renowned dermatology and plastic surgery clinics (as of 2024) incorporated COIZ’s reliable post-care programs, receiving consistently positive feedback.

OxygenCeuticals’ Oxygen Soothing Solutions (Cosmetics)

With a range of over 150 pure oxygen infused skincare products, OxygenCeuticals’ flagship items include:

Sukalming Derma Kit: Designed to reduce post-procedure bruising and pigmentation while soothing and regenerating the skin.

Skin Barrier Ato Cream: A non-irritating cream that strengthens the skin barrier and maintains oil-water balance.

Moisture Aqua Serum: A hyaluronic acid-based moisture serum that delivers intense hydration and a rich moisturizing effect.

ACELL 300 Fluid: Formulated with the patented ACELL-300 ingredient, it helps minimize moisture loss and provides a dewy, radiant look.

Riding on its popularity, Oxygenceuticals is set to welcome customers worldwide with exciting offers during this Black Friday and year-end season. From November 27 to 29, enjoy a 30% discount on OxygenCeuticals skincare products for three days only (code: BLACK30).

In addition, during the December promotion, from December 1 to 31, all Oxygenceuticals skincare kits will be available at a 20% discount (code: GIFTME).

COIZ CEO Woo Ji-san stated, “With the increasing trend of cosmetic procedures focused not just on beauty but on health, there is growing attention on post-procedure skincare.

To demonstrate the excellence of OxygenCeuticals products, we consistently participate in global exhibitions, where our products have gained recognition from numerous buyers and distributors. Our oxygen-based beauty devices, specifically designed for post-care using pure oxygen—a natural element closest to the human body—are cherished worldwide, beyond just Korea. We provide post-care oxygen beauty device solutions that include Oxygenceuticals products. In gratitude for the love and support from our customers, we are offering this promotion with the highest discount rates.”

Company name: OxygenCeuticals North America

Name: Eunice Cher

Email: sales@oxyfacial.com

Division: USA Branch

Address: 1007 N Orange Street, 4th Floor, Unit 500, Wilmington DE 19801

Phone: 434-696-8888

Website: us.oxygenceuticals.com

Zhuding International Limited (OTC: ZHUD), a Nevada corporation, and Automated Water Solutions Inc., (AWS), a Texas corporation, are pleased to announce the signing of a Reverse Merger Agreement for the acquisition of AWS by ZHUD that will result in AWS having control over ZHUD. The effective date of the merger is 10/31/24.

An application for name change has been filed and the new name of the entity will be  Automated Water Solutions Inc.. A stock symbol change will be forthcoming also. The new board of directors will be W. Kyle Lewis, John H. Slocum, Dennis M Sheib, Josh Cohen, and Jon M. Andrews.

Automated Water Solutions Inc. “AWS” started as a vision over five years ago of where produced water recycling efficiency needed to be. Research and observation of the technologies that go into making produced water reuse effective and economical has culminated into this company. Utilizing automation throughout the water clean-up process and efficient G&A cost allows our cost per barrel to be lower than our competitors and ultimately save the customer millions of dollars per year while providing a product that is consistent to their specifications.

AWS will provide customers with a superior process for recycling produced water using Ozone and nanobubble technology whether it be a complete TSS removal  process or a more simple disinfection and filtration process. Both processes are completely automated and volumes of up to 80,000  barrels per day of throughput can be achieved. AWS will have turnkey options for customers including above ground storage tank (AST) rental, frac pond construction, generator rental, skim oil recovery and automation installation in addition to our produced water recycling systems.

Controlled Investments acted as an Advisor to the Transaction.  Controlled Investments is a capital investment firm led by Josh Cohen that has raised $310 million in committed capital this year and has acted as an advisor or co-advisor to over $1.3 billion in consummated transactions over the past decade.

As a result of AWS and its technology capabilities, both parties anticipate a bright future for present and future shareholders. 

As part of the transaction, AWS will  will pay Belisarian Holdings, LLC. $325,000 over a six-month period and issue to the same a two percent equity stake, which is subject to a two-year holding period, in settlement of debts owed to Belisarian and in consideration of the sale of preferred stock held by Belisarian. Controlled Investments is a guarantor on this transaction.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words “may,” “should,” “plans,” “expects,” “anticipates,” “continue,” “estimates,” “projects,” “intends,” and similar expressions. Forward looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, the company’s ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond the Company’s control.

Media Details:

Company Name: Belisarian Holdings , Zhuding International Limited

Contact person: Dilan Gonzalez 

dilangonzalez@belisarianholdings.com

https://www.otcmarkets.com/stock/ZHUD/profile

https://www.instagram.com/p/C_x8_dtp1Dh/?igsh=MXJ2OGxjOTFqaGF0MQ==

Delayed diagnosis can have severe, life-altering effects on patients, resulting in lasting physical, emotional, and financial challenges. This press release explores the profound impacts of diagnostic delays and highlights the critical need for timely, quality healthcare.

Phoenix, Arizona, United States, 16th Nov 2024 — Delayed diagnosis in healthcare can have devastating effects on patients, often leading to irreversible health outcomes. When symptoms are missed or treatment is postponed, conditions can rapidly worsen, leaving individuals and their families facing enormous physical and emotional challenges. For patients like Stephanie VanEmst, a mother from Peoria who experienced permanent paralysis, the consequences of delayed diagnosis have reshaped her life in unimaginable ways.

Diagnostic delays can impact patients on many levels. Physically, untreated conditions may progress, potentially leading to severe disability or, in extreme cases, fatality. The emotional toll of living with a condition that might have been treated earlier can lead to feelings of frustration, anxiety, and a loss of trust in medical systems. Financially, the burden of ongoing medical care, rehabilitation, and assistive support can be overwhelming, impacting the quality of life not just for patients but for their entire families.

The importance of prompt, accurate diagnosis cannot be overstated. Hospitals and healthcare providers are tasked with the responsibility of ensuring that patients receive timely assessments and appropriate care to mitigate the risk of severe complications. Advocates for patient rights stress that when healthcare teams follow best practices and uphold high standards, the risk of diagnostic delays—and their potentially tragic consequences–can be significantly reduced.

About Gage Mathers Law Group: Gage Mathers Law Group is an established advocate for individuals impacted by medical negligence, working to uphold standards of care and support victims on their path to recovery.

Media Contact

Organization: Gage Mathers Law Group

Contact Person: Joseph D’Aguanno

Website: https://gagemathers.com/

Email: Send Email

Contact Number: +16022580646

Address: 2525 E Arizona Biltmore Cir #A114

City: Phoenix

State: Arizona

Country: United States

Release Id: 16112418927

The post Impact of Delayed Diagnosis on Patients: A Look at the Life-Changing Consequences appeared on King Newswire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it.